Orbit Genomics is proud to announce that we have been named a finalist in the Startup Prize Focus on Health competition, an initiative that spotlights transformative innovation in healthcare and life sciences.
This recognition highlights the impact and potential of our patented OrbiSeq™ platform, an AI-powered approach to transform diagnosis, treatment and prevention of complex diseases including cancer, heart disease and neurological diseases.
As a finalist, Orbit Genomics joins a select group of startups recognized for advancing scalable solutions to some of today’s most urgent health challenges. The Focus on Health program connects emerging companies with leading investors, strategic partners, and healthcare innovators who are committed to meaningful change.
“Being named a finalist in the Startup Prize Focus on Health is a meaningful milestone for Orbit,” said Dede Willis, CEO of Orbit Genomics. “It reinforces the strength of our science, our team, and our commitment to delivering earlier, more actionable insights that can change the trajectory of disease.”
We are honored by this recognition and grateful to the Startup Prize team for their support. We remain focused on delivering precision health solutions that improve outcomes—and unlock a new era in proactive, personalized care.